跳至主要内容
临床试验/JPRN-UMIN000010722
JPRN-UMIN000010722已完成未知

The clinical and bacteriological efficacy of Doripenem (DRPM) in patients with infections by Extended-spectrum beta-lactamase (ESBLs)-producing strains: non-randomized, open, label, multi-centre study. - The clinical and bacteriological efficacy of DRPM in patients with infections by ESBL-producing strains.

Department of Clinical Infectious Diseases, Aichi Medical Univertisy Hospital0 个研究点目标入组 200 人开始时间: 2013年5月14日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
16years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Hisotry of spilepsy. Neurological symptoms with convulsions. 2) History of hypersensitivity, allergy or serious adverse drug event caused by beta-lactam antibiotics. 3) Woman who are pregnant and breast-feeding or suspected to be pregnant. 4) Any other patients whose condition is inappropriate for the evaluation of this clinical study as judged by the investigator.

研究者

发起方
Department of Clinical Infectious Diseases, Aichi Medical Univertisy Hospital

相似试验